Resources

Publish Date
Letters
C4IP Letter to USPTO and DOJ RE: Statement of Interest on Injunctions
Letters
C4IP Letter to European Commission RE: EU IPRED Study
Letters
C4IP Letter to Senate Judiciary Committee RE: Hearing on China and IP Theft
Congressional Innovation ScorecardReports
The Congressional Innovation Scorecard: Third Edition
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Hearing on Codes Development
External ResourcesReports
An Unbalanced Proposal: Licensing Negotiation Groups for Wireless Technology in the Automotive Industry
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: U.S. Patent and Trademark Office
Public Comments
C4IP Post-Hearing Comments RE: The 2026 Special 301 Review (USTR-2025-0243)
Public Comments
C4IP Comments RE: The 2026 Special 301 Review (USTR-2025-0243)
Public Comments
C4IP Response RE: OSTP RFI on Accelerating American Scientific Enterprise
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: the American Music Fairness Act of 2025
Letters
C4IP Letter to USTR RE: US-EU Trade Agreement
Resources:

Resources:

C4IP Written Submission for Inv. No. 332-596,

04/26/2023

Resources:

Resources:

Public Comments on European Commission Draft SEP Regulation,

04/19/2023

Resources:

Resources:

C4IP Response to CMS Solicitation of Comments Concerning Initial Guidance on the Inflation Reduction Act’s (IRA) Medicare Drug Negotiation Program,

04/14/2023

Resources:

Resources:

C4IP Post-Hearing Brief RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023

Resources:

Resources:

C4IP Testimony RE: U.S. International Trade Commission Investigation No. 332-596: COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities,

03/29/2023

Resources:

Resources:

C4IP Letter to Senate HELP Committee RE: The Bayh-Dole Act and 28 U.S. Code § 1498,

03/17/2023

Resources:

Resources:

C4IP Comments RE: Joint USPTO-FDA Collaboration Initiatives (PTO-P-2022-0037),

03/10/2023

Resources:

Resources:

C4IP Comments RE: Certain Light-Based Physiological Measurement Devices and Components Thereof (337-TA-1276),

02/23/2023

Resources:

Resources:

C4IP Comments RE: Request for Comments on USPTO Initiatives To Ensure the Robustness and Reliability of Patent Rights (PTO-P-2022-0025),

01/31/2023

Resources:

Resources:

IP, Innovation, and American Universities, Bayh-Dole Coalition,

01/15/2023

Resources:

Resources:

C4IP Letter to Secretary Becerra RE: Xtandi March-In Petition,

12/15/2022

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: The Interagency Patent Coordination and Improvement Act of 2022,

12/13/2022

Scroll to Top